Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C59H84N16O12 |
Molecular Weight | 1209.3983 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 9 / 9 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=C3C=CC=C4)NC(=O)[C@H](CC5=CNC=N5)NC(=O)[C@@H]6CCC(=O)N6
InChI
InChIKey=GFIJNRVAKGFPGQ-LIJARHBVSA-N
InChI=1S/C59H84N16O12/c1-6-63-57(86)48-14-10-22-75(48)58(87)41(13-9-21-64-59(60)61)68-51(80)42(23-32(2)3)69-52(81)43(24-33(4)5)70-53(82)44(25-34-15-17-37(77)18-16-34)71-56(85)47(30-76)74-54(83)45(26-35-28-65-39-12-8-7-11-38(35)39)72-55(84)46(27-36-29-62-31-66-36)73-50(79)40-19-20-49(78)67-40/h7-8,11-12,15-18,28-29,31-33,40-48,65,76-77H,6,9-10,13-14,19-27,30H2,1-5H3,(H,62,66)(H,63,86)(H,67,78)(H,68,80)(H,69,81)(H,70,82)(H,71,85)(H,72,84)(H,73,79)(H,74,83)(H4,60,61,64)/t40-,41-,42-,43+,44-,45-,46-,47-,48-/m0/s1
Molecular Formula | C59H84N16O12 |
Molecular Weight | 1209.3983 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 9 / 9 |
E/Z Centers | 3 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:53:43 UTC 2023
by
admin
on
Sat Dec 16 16:53:43 UTC 2023
|
Record UNII |
EFY6W0M8TG
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
L02AE51
Created by
admin on Sat Dec 16 16:53:43 UTC 2023 , Edited by admin on Sat Dec 16 16:53:43 UTC 2023
|
||
|
NDF-RT |
N0000175654
Created by
admin on Sat Dec 16 16:53:43 UTC 2023 , Edited by admin on Sat Dec 16 16:53:43 UTC 2023
|
||
|
NDF-RT |
N0000009332
Created by
admin on Sat Dec 16 16:53:43 UTC 2023 , Edited by admin on Sat Dec 16 16:53:43 UTC 2023
|
||
|
WHO-VATC |
QL02AE02
Created by
admin on Sat Dec 16 16:53:43 UTC 2023 , Edited by admin on Sat Dec 16 16:53:43 UTC 2023
|
||
|
NDF-RT |
N0000175655
Created by
admin on Sat Dec 16 16:53:43 UTC 2023 , Edited by admin on Sat Dec 16 16:53:43 UTC 2023
|
||
|
NCI_THESAURUS |
C1910
Created by
admin on Sat Dec 16 16:53:43 UTC 2023 , Edited by admin on Sat Dec 16 16:53:43 UTC 2023
|
||
|
WHO-ATC |
L02AE02
Created by
admin on Sat Dec 16 16:53:43 UTC 2023 , Edited by admin on Sat Dec 16 16:53:43 UTC 2023
|
||
|
LIVERTOX |
NBK548676
Created by
admin on Sat Dec 16 16:53:43 UTC 2023 , Edited by admin on Sat Dec 16 16:53:43 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
5025
Created by
admin on Sat Dec 16 16:53:43 UTC 2023 , Edited by admin on Sat Dec 16 16:53:43 UTC 2023
|
PRIMARY | |||
|
Leuprorelin
Created by
admin on Sat Dec 16 16:53:43 UTC 2023 , Edited by admin on Sat Dec 16 16:53:43 UTC 2023
|
PRIMARY | |||
|
SUB08449MIG
Created by
admin on Sat Dec 16 16:53:43 UTC 2023 , Edited by admin on Sat Dec 16 16:53:43 UTC 2023
|
PRIMARY | |||
|
EFY6W0M8TG
Created by
admin on Sat Dec 16 16:53:43 UTC 2023 , Edited by admin on Sat Dec 16 16:53:43 UTC 2023
|
PRIMARY | |||
|
C62042
Created by
admin on Sat Dec 16 16:53:43 UTC 2023 , Edited by admin on Sat Dec 16 16:53:43 UTC 2023
|
PRIMARY | |||
|
42375
Created by
admin on Sat Dec 16 16:53:43 UTC 2023 , Edited by admin on Sat Dec 16 16:53:43 UTC 2023
|
PRIMARY | RxNorm | ||
|
m6779
Created by
admin on Sat Dec 16 16:53:43 UTC 2023 , Edited by admin on Sat Dec 16 16:53:43 UTC 2023
|
PRIMARY | Merck Index | ||
|
EFY6W0M8TG
Created by
admin on Sat Dec 16 16:53:43 UTC 2023 , Edited by admin on Sat Dec 16 16:53:43 UTC 2023
|
PRIMARY | |||
|
DB00007
Created by
admin on Sat Dec 16 16:53:43 UTC 2023 , Edited by admin on Sat Dec 16 16:53:43 UTC 2023
|
PRIMARY | |||
|
53714-56-0
Created by
admin on Sat Dec 16 16:53:43 UTC 2023 , Edited by admin on Sat Dec 16 16:53:43 UTC 2023
|
PRIMARY | |||
|
100000088225
Created by
admin on Sat Dec 16 16:53:43 UTC 2023 , Edited by admin on Sat Dec 16 16:53:43 UTC 2023
|
PRIMARY | |||
|
1175
Created by
admin on Sat Dec 16 16:53:43 UTC 2023 , Edited by admin on Sat Dec 16 16:53:43 UTC 2023
|
PRIMARY | |||
|
1559
Created by
admin on Sat Dec 16 16:53:43 UTC 2023 , Edited by admin on Sat Dec 16 16:53:43 UTC 2023
|
PRIMARY | |||
|
DTXSID50872411
Created by
admin on Sat Dec 16 16:53:43 UTC 2023 , Edited by admin on Sat Dec 16 16:53:43 UTC 2023
|
PRIMARY | |||
|
657181
Created by
admin on Sat Dec 16 16:53:43 UTC 2023 , Edited by admin on Sat Dec 16 16:53:43 UTC 2023
|
PRIMARY | |||
|
CHEMBL1201199
Created by
admin on Sat Dec 16 16:53:43 UTC 2023 , Edited by admin on Sat Dec 16 16:53:43 UTC 2023
|
PRIMARY | |||
|
377526
Created by
admin on Sat Dec 16 16:53:43 UTC 2023 , Edited by admin on Sat Dec 16 16:53:43 UTC 2023
|
PRIMARY | |||
|
6427
Created by
admin on Sat Dec 16 16:53:43 UTC 2023 , Edited by admin on Sat Dec 16 16:53:43 UTC 2023
|
PRIMARY | |||
|
6518
Created by
admin on Sat Dec 16 16:53:43 UTC 2023 , Edited by admin on Sat Dec 16 16:53:43 UTC 2023
|
PRIMARY | |||
|
D016729
Created by
admin on Sat Dec 16 16:53:43 UTC 2023 , Edited by admin on Sat Dec 16 16:53:43 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE INACTIVE -> PARENT |
MAJOR
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
Males PHARMACOKINETIC |
|
||